Iron replacement agent

14 marketed 4 in Phase 3

This page covers all Iron replacement agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Iron (Fe3+) for hemoglobin and myoglobin synthesis, Transferrin receptor (indirect); iron supplementation, Iron metabolism pathway; transferrin receptor.

Targets

Iron (Fe3+) for hemoglobin and myoglobin synthesis · Transferrin receptor (indirect); iron supplementation · Iron metabolism pathway; transferrin receptor · Iron (Fe3+) / transferrin receptor · Iron (Fe3+) delivery system · Iron (Fe3+) delivery; hemoglobin and myoglobin synthesis · Iron metabolism / transferrin-mediated iron transport · Iron metabolism pathway · Transferrin (iron transport protein) · Iron transporter (DMT1/SLC11A2)

Marketed (14)

Phase 3 pipeline (4)